Toews Corporation’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,000
Closed -$779K 64
2023
Q3
$779K Buy
+5,000
New +$825K 0.47% 31
2023
Q1
Sell
-4,400
Closed -$777K 74
2022
Q4
$777K Sell
4,400
-2,800
-39% -$483K 0.38% 54
2022
Q3
$1.18M Buy
7,200
+200
+3% +$33.8K 0.86% 8
2022
Q2
$1.24M Buy
7,000
+4,700
+204% +$837K 0.83% 15
2022
Q1
$408K Buy
+2,300
New +$391K 0.07% 48
2021
Q4
Sell
-2,500
Closed -$404K 72
2021
Q3
$404K Buy
+2,500
New +$427K 0.05% 88
2021
Q2
Sell
-5,700
Closed -$937K 71
2021
Q1
$937K Buy
+5,700
New +$922K 0.08% 83
2020
Q4
Sell
-6,700
Closed -$997K 72
2020
Q3
$997K Buy
+6,700
New +$991K 0.3% 47
2020
Q2
Sell
-6,900
Closed -$905K 65
2020
Q1
$905K Buy
+6,900
New +$979K 0.82% 31
2019
Q1
Sell
-7,400
Closed -$955K 62
2018
Q4
$955K Buy
+7,400
New +$1.03M 0.41% 64
2018
Q3
Sell
-2,800
Closed -$340K 56
2018
Q2
$340K Sell
2,800
-4,400
-61% -$549K 0.08% 82
2018
Q1
$923K Buy
+7,200
New +$973K 0.3% 43
2016
Q3
Sell
-5,200
Closed -$631K 55
2016
Q2
$631K Buy
+5,200
New +$591K 0.27% 13

Other funds holding JNJ

Toews Corporation's JNJ Position: Q4 2023 in Review

Toews Corporation sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 5,000 shares — an estimated $779K sold.

Toews Corporation first reported a position in JNJ in Q2 2016 and held it in 13 quarters. The position peaked at $1.24M in Q2 2022. 3,869 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Toews Corporation reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
  • Toews Corporation sold 5,000 Johnson & Johnson shares in Q4 2023, an estimated $779K.
  • Toews Corporation first reported a position in Johnson & Johnson in Q2 2016 and held it in 13 quarters.
  • Toews Corporation's Johnson & Johnson position peaked at $1.24M in Q2 2022.
  • 3,869 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.